{"id":47277,"date":"2022-08-15T14:01:45","date_gmt":"2022-08-15T12:01:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/"},"modified":"2022-08-15T14:01:45","modified_gmt":"2022-08-15T12:01:45","slug":"lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/","title":{"rendered":"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference"},"content":{"rendered":"
\n

CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX<\/a> #LineageCellTherapeutics<\/a>—Lineage Cell Therapeutics, Inc.<\/a> (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today Brian M. Culley, Lineage\u2019s Chief Executive Officer, will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference<\/a>, in a fireside chat hosted by Joseph Pantginis, Ph.D., Director of Research; Managing Director, Equity Research, H. C. Wainwright & Co. LLC. The fireside chat will be available to investors on demand, starting on August 17th<\/sup>, 2022 at 7am ET.\n<\/p>\n

<\/a><\/p>\n

\nInterested parties can register to view on-demand replay on the Events and Presentations<\/a> section of Lineage\u2019s website. Additional videos are available on the Media<\/a> page of the Lineage website.\n<\/p>\n

\nAbout Lineage Cell Therapeutics, Inc.<\/b>\n<\/p>\n

\nLineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage\u2019s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage\u2019s clinical programs are in markets with billion dollar opportunities and include five allogeneic (\u201coff-the-shelf\u201d) product candidates: (i) OpRegen, a retinal pigment epithelial cell therapy in development for the treatment of geographic atrophy secondary to age-related macular degeneration, is being developed<\/a> under a worldwide collaboration with Roche and Genentech, a member of the Roche Group; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1\/2a development for the treatment of acute spinal cord injuries; (iii) VAC2, a dendritic cell therapy produced from Lineage\u2019s VAC technology platform for immuno-oncology and infectious disease, currently in Phase 1 clinical development for the treatment of non-small cell lung cancer; (iv) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; and (v) PNC1, a photoreceptor neural cell therapy for the treatment of vision loss due to photoreceptor dysfunction or damage. For more information, please visit www.lineagecell.com<\/a> or follow the company on Twitter @LineageCell<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLineage Cell Therapeutics, Inc. IR<\/b>
Ioana C. Hone
\n
(ir@lineagecell.com<\/a>)
\n
(442) 287-8963\n<\/p>\n

\nRusso Partners \u2013 Media Relations<\/b>
Nic Johnson or David Schull
\n
Nic.johnson@russopartnersllc.com<\/a>
David.schull@russopartnersllc.com<\/a>
(212) 845-4242\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #LineageCellTherapeutics—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today Brian M. Culley, Lineage\u2019s Chief Executive Officer, will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference, in a fireside chat hosted by Joseph Pantginis, Ph.D., Director of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47277","6":"format-standard","7":"category-industry"},"yoast_head":"\nLineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #LineageCellTherapeutics—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today Brian M. Culley, Lineage\u2019s Chief Executive Officer, will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference, in a fireside chat hosted by Joseph Pantginis, Ph.D., Director of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-15T12:01:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220815005164\/en\/737852\/21\/LINEAGE_SCREEN_JPEG_1800x360.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference\",\"datePublished\":\"2022-08-15T12:01:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/\"},\"wordCount\":420,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005164\\\/en\\\/737852\\\/21\\\/LINEAGE_SCREEN_JPEG_1800x360.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/\",\"name\":\"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005164\\\/en\\\/737852\\\/21\\\/LINEAGE_SCREEN_JPEG_1800x360.jpg\",\"datePublished\":\"2022-08-15T12:01:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005164\\\/en\\\/737852\\\/21\\\/LINEAGE_SCREEN_JPEG_1800x360.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220815005164\\\/en\\\/737852\\\/21\\\/LINEAGE_SCREEN_JPEG_1800x360.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference - Pharma Trend","og_description":"CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #LineageCellTherapeutics—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today Brian M. Culley, Lineage\u2019s Chief Executive Officer, will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference, in a fireside chat hosted by Joseph Pantginis, Ph.D., Director of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-15T12:01:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220815005164\/en\/737852\/21\/LINEAGE_SCREEN_JPEG_1800x360.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference","datePublished":"2022-08-15T12:01:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/"},"wordCount":420,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220815005164\/en\/737852\/21\/LINEAGE_SCREEN_JPEG_1800x360.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/","url":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/","name":"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220815005164\/en\/737852\/21\/LINEAGE_SCREEN_JPEG_1800x360.jpg","datePublished":"2022-08-15T12:01:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220815005164\/en\/737852\/21\/LINEAGE_SCREEN_JPEG_1800x360.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220815005164\/en\/737852\/21\/LINEAGE_SCREEN_JPEG_1800x360.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lineage-to-present-at-h-c-wainwright-co-2nd-annual-virtual-ophthalmology-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47277"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47277\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}